Trust Size
$114M
Peak Price
$37.55
Current Price
$5.00
Return
-44.3%
Price Journey
What Happened
Zura Bio is a clinical-stage biotechnology company developing novel medicines for immune and inflammatory disorders. Founded in 2022, the company went public via SPAC and is headquartered in Henderson, Nevada.
Zura Bio went public via SPAC merger in 2022. The company is developing treatments for immune disorders and remains in clinical stage. It was misclassified as bankrupt and continues to trade on Nasdaq.
Timeline
2021-07-06
S-1 Registration Filed
SEC Filing Details
CIK Number
1855644
Total SEC Filings
408
State of Incorporation
E9
Last Filing Date
2026-03-19
Business Location
Grand Cayman, E9
Trust/Asset Size
$114M
Data sourced from SEC EDGAR Company Facts API and EFTS search index.
📄 SEC Filings
View all EDGAR filings for Zura Bio